Taking Research to the Patient
BVBiomed ltd. is a research driven company dedicated to the discovery of novel therapeutic compounds for use in treating neuro-degenerative diseases. We have currently completed the pre-clinical phase with one new compound which is anti-inflammatory, immune regulating, neuroprotective and enhancer of remyelination in vivo.
A phase IIa clinical trial is being prepared in collaboration with the MS Unit at University College London. This will focus on the treatment of multiple sclerosis.
For additional information on our programs or partnering please contact us.
BVBiomed Ltd. 2019
BVBiomed Ltd. was founded in 2012. Building on our novel therapuetics for neurodegenerative diseases. We are a drug discovery company.